GSK’s Tafinlar named as FDA breakthrough therapy for lung cancer
The logo of GlaxoSmithKline (GSK) is seen on its office building in Shanghai July 12, 2013.
Credit: Reuters/Aly Song
Read the original here:
feeds.reuters
Healthy Living News From around The Web
GSK’s Tafinlar Named As FDA Breakthrough Therapy For Lung Cancer – Fox Business